본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation Kang EunKyo
(Division of Cancer Early Detection)


()
. The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation. TOBACCO INDUCED DISEASES. 2024-02-14; 2024; 22:37~. IF 2.2 (2023)
A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules
()

Lee Eun Kyung
(Targeted Therapy Branch)
. A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules. Endocrinology and Metabolism. 2024-02-14; 2024; 39(1):61~72. IF 3.9 (2023)
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy Han Ji-Youn
(Anticancer Resistance Branch )

Kim, Sun Shin
(Targeted Therapy Branch)
. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers. 2024-02-14; 2024; 16(4):778~. IF 4.5 (2023)
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer Kim Yun-Hee
(Cancer Molecular Imaging Branch)

Lee Mi Rim
(Cancer Molecular Imaging Branch)
. Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer. CANCER SCIENCE. 2024-02-13; 2024; 115(4):1283~1295. IF 4.5 (2023)
Impact of Coronavirus Disease 2019 on Cancer Care: How the Pandemic has Changed Cancer Utilization and Expenditures Kim, Young Ae
(Division of Cancer Management Policy)


()
. Impact of Coronavirus Disease 2019 on Cancer Care: How the Pandemic has Changed Cancer Utilization and Expenditures. PLOS ONE. 2024-02-08; 2024; 19(2):e0296808~. IF 2.9 (2023)
Toward Deploying a Deep Learning Model for Diagnosis of Rhabdomyosarcoma
()

Ho David Joon
(Department of Cancer AI and Digital Health)
. Toward Deploying a Deep Learning Model for Diagnosis of Rhabdomyosarcoma. MODERN PATHOLOGY. 2024-02-08; 2024; 37(3):100421~. IF 7.1 (2023)
Cancer risk following Smoking cessation in Korea Oh J K
(Department of Clinical Nursing Science)

Park Eunjung
(Department of Cancer Control and Population Health)
. Cancer risk following Smoking cessation in Korea. JAMA NETWORK OPEN. 2024-02-06; 2024; 7(2):e2354958~. IF 10.5 (2023)
Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey Sun-Young Kong
(Targeted Therapy Branch)

Sun-Young Kong
(Targeted Therapy Branch)
. Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2024-02-06; 2024; 30:1~9. IF 2.3 (2023)
The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer Jung Yuh Seog
(Division of Cancer Data Science )

Kim Seok Ki
(Cancer Molecular Imaging Branch)
. The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer. ANNALS OF SURGICAL ONCOLOGY. 2024-02-02; 2024; 31:2349~2356. IF 3.4 (2023)
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study
()

Shin Hyunjae
(Branch of Gastroenterology)
. Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study. HEPATOLOGY RESEARCH. 2024-02-01; 2024; 54(7):627~637. IF 3.9 (2023)
First page Prev paging 31 32 33 34 35 36 37 38 39 40 next paging last page